Breast Ultrasound Market Analysis

Breast Ultrasound Market Analysis

Based on product type, the breast ultrasound market is segmented into conventional ultrasound and automated ultrasound. Automated breast ultrasound segment is anticipated to exhibit enormous growth over the estimated period. The growth can be attributed to increasing adoption of automated breast ultrasound (ABUS) devices. These devices use computer-aided detection (CAD) software to produce a 3D image of the breast, which allows for a more comprehensive evaluation of breast tissue and increases the accuracy level of detecting breast cancer. Automated ultrasound devices are particularly useful in combination with traditional mammography screening to provide additional information for a more thorough evaluation, thereby stimulating product adoption.
 

The breast ultrasound market is segmented by end-use into hospitals, diagnostic laboratories, and others. The hospital segment is projected to witness substantial market growth over the forecast period. The demand for breast ultrasound systems has increased remarkably over recent years especially owing to the increasing prevalence of breast cancer worldwide. Hospitals are incorporating breast ultrasound technology into their cancer screening and diagnostic services, utilizing the latest trends to provide more accurate, efficient, and accessible breast cancer screening and diagnostic services to their patients bolstering segment growth potential.
 

U.S. breast ultrasound market accounted for more than USD 825 million in 2022 and will grow momentously more than USD 1694 million by 2032. The affordability of breast ultrasound devices among the target population base and ongoing technological developments are primarily responsible for the growth of the regional market. Further, the region's high healthcare spending on health care management and rising disposable income will propel the expansion of the North America market. Also, the substantial presence of well-established market participants and the favourable regulatory environment result in a number of product approvals and launches, particularly in the U.S.